Correspondence to: 'Post hoc comparison of the effectiveness of tocilizumab, rituximab, mycophenolate mofetil, and cyclophosphamide in patients with SSc-ILD from the EUSTAR database'.

IF 20.3 1区医学 Q1 RHEUMATOLOGY

Annals of the Rheumatic Diseases Pub Date : 2025-06-18 DOI:10.1016/j.ard.2025.04.026

Yan-Li Yang, Rong-Hong Guo, James Cheng-Chung Wei, Li-Yun Zhang

引用次数: 0

查看原文本刊更多论文

对应于：“EUSTAR数据库中托珠单抗、利妥昔单抗、霉酚酸酯和环磷酰胺对SSc-ILD患者疗效的事后比较”。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Annals of the Rheumatic Diseases 医学-风湿病学

CiteScore

35.00

自引率

9.90%

发文量

3728

审稿时长

1.4 months

期刊介绍： Annals of the Rheumatic Diseases (ARD) is an international peer-reviewed journal covering all aspects of rheumatology, which includes the full spectrum of musculoskeletal conditions, arthritic disease, and connective tissue disorders. ARD publishes basic, clinical, and translational scientific research, including the most important recommendations for the management of various conditions.